However, healthy donor CD4+ and CD8+ T cells stimulated with phorbol 12-myristate 13-acetate (PMA) and ionomycin had a significantly lower percentage of TIM-3 positivity compared to stimulated CD4+ and CD8+ T cells from glioblastoma patients [35]. This evidence concerns the gene CD8A and glioblastoma.